利用聚多巴胺制备丹参注射液缓释制剂的研究
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家重点研发计划项目(2018YFC1706905)——中医药现代化研究;苏州市科技发展计划基金项目(SYSD2019187,SYSD2018242)


Study on Preparation of Danshen Injection Sustained-release Preparation Using Polydopamine
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:利用聚多巴胺(PDA)对丹参注射液中多成分进行负载,构建丹参注射液(SMI)缓释制剂(PDA-SMI)。方法:建立丹参注射液的原儿茶醛、迷迭香酸和丹酚酸B3种成分的分析方法并进行含量测定;制备PDA,在pH值2.5的条件下对SMI进行负载,制备PDA-SMI;对PDA-SMI体外释放行为进行考察。结果:SMI中原儿茶醛、迷迭香酸、丹酚酸B的浓度分别为0.344、0.214、0.262 mg/mL;PDA-SMI对原儿茶醛、迷迭香酸、丹酚酸B的载药量分别为8.59%,15.90%和20.57%;PDA-SMI中原儿茶醛、迷迭香酸、丹酚酸B体外累计释放率分别为84.05%,77.57%和63.12%。结论:PDA可以负载SMI的多种成分,载药量较高,并具有良好的缓释效应。

    Abstract:

    To use polydopamine(PDA)to carry out multiple components of Salvia miltiorrhiza injection,and to construct a slow-release preparation of Salvia miltiorrhiza injection(SMI)(PDA-SMI).Methods:Establish the analysis method of the three components of protocatechuic aldehyde,rosmarinic acid and salvianolic acid B of Salvia miltiorrhiza injection and determine the content; prepare PDA,load SMI under the condition of pH 2.5 to prepare PDA-SMI; The in vitro release behavior of PDA-SMI was investigated.Results:The concentrations of protocatechuic aldehyde,rosmarinic acid and salvianolic acid B in SMI were 0.344,0.214 and 0.262 mg/mL,respectively; the loading of protocatechuic aldehyde,rosmarinic acid and salvianolic acid B by PDA-SMI The doses were 8.59%,15.90% and 20.57% respectively; the cumulative release rates of protocatechuic aldehyde,rosmarinic acid and salvianolic acid B in PDA-SMI were 84.05%,77.57% and 63.12%,respectively.Conclusion:PDA can load multiple components of SMI and has a good sustained-release effect.

    参考文献
    相似文献
    引证文献
引用本文

朱辰奇,顾依,周琴,刘馨,沈惠明,陈志鹏.利用聚多巴胺制备丹参注射液缓释制剂的研究[J].世界中医药,2020,(15).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-07-01
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-08-14
  • 出版日期:
文章二维码